# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-130745
Filing Date
2018-04-25
Accepted
2018-04-25 12:33:05
Documents
23
Period of Report
2018-06-05
Effectiveness Date
2018-04-25

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d562596ddef14a.htm | DEF 14A | 1737459
2 | GRAPHIC | g562596g11r84.jpg | GRAPHIC | 33180
3 | GRAPHIC | g562596g14e01.jpg | GRAPHIC | 25324
4 | GRAPHIC | g562596g21r93.jpg | GRAPHIC | 24690
5 | GRAPHIC | g562596g22q87.jpg | GRAPHIC | 281698
6 | GRAPHIC | g562596g23k78.jpg | GRAPHIC | 31267
7 | GRAPHIC | g562596g31c02.jpg | GRAPHIC | 43551
8 | GRAPHIC | g562596g32v27.jpg | GRAPHIC | 29159
9 | GRAPHIC | g562596g36v34.jpg | GRAPHIC | 31005
10 | GRAPHIC | g562596g52m79.jpg | GRAPHIC | 36363
11 | GRAPHIC | g562596g54q16.jpg | GRAPHIC | 42364
12 | GRAPHIC | g562596g58w78.jpg | GRAPHIC | 29573
13 | GRAPHIC | g562596g62p97.jpg | GRAPHIC | 35054
14 | GRAPHIC | g562596g69x47.jpg | GRAPHIC | 35138
15 | GRAPHIC | g562596g70w96.jpg | GRAPHIC | 33096
16 | GRAPHIC | g562596g73h83.jpg | GRAPHIC | 41063
17 | GRAPHIC | g562596g91e40.jpg | GRAPHIC | 31890
18 | GRAPHIC | g562596g91r20.jpg | GRAPHIC | 30133
19 | GRAPHIC | g562596g92v35.jpg | GRAPHIC | 28823
20 | GRAPHIC | g562596g93v53.jpg | GRAPHIC | 28998
21 | GRAPHIC | g562596g95v27.jpg | GRAPHIC | 34041
22 | GRAPHIC | g562596g96t45.jpg | GRAPHIC | 61276
23 | GRAPHIC | g562596g97t06.jpg | GRAPHIC | 29592
| Complete submission text file | 0001193125-18-130745.txt |  | 3102039

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-16174 | Film No.: 18773507
SIC: 2834 Pharmaceutical Preparations